Seretide (salmeterol 50mcg/fluticasone propionate 100mcg BID) compared with budesonide (400mcg BID) in mild to moderate asthma.

被引：0

作者：

Johansson, G

McIvor, RA

D'Ambrosio, FP

Gratziou

James, MH

机构：

[1] Nyby Hlth Ctr, Uppsala, Sweden

[2] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada

[3] Policlin Univ Messina, Messina, Italy

[4] Evenidion Hosp, Athens, Greece

[5] Glaxo Wellcome Res & Dev Ltd, Uxbridge, Middx, England

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 1999年 / 159卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：A637 / A637

页数：1

共 24 条

[1] Fluticasone propionate 50mcg bid and 100mcg bid improves functional status and decreases sleep disturbances in children with asthma
Mahajan, P
Okamoto, L
Bosh, T
Kellerman, D
Baker, K
Bronsky, E
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 697 - 697
[2] Advair™/Seretide™ (salmeterol 50mcg/fluticasone propionate 250 meg bid) compared with budesonide (800 meg bid) during the first week of treatment of moderate asthma
Jenkins, C
Woolcock, A
Saarelainen, P
James, M
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S161 - S161
[3] Addition of salmeterol 50mcg bid to anticholinergic treatment in COPD
Chapman, K
Kuipers, AF
Goldstein, R
James, MH
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A523 - A523
[4] Salmeterol 50mcg/fluticasone propionate 100mcg diskus combination product demonstrates improvements in lung function regardless of baseline corticosteroid therapy
LaForce, C
Woodring, A
Baitinger, L
House, K
Prillaman, B
Shah, T
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (01) : S12 - S12
[5] Effects Of Fluticasone Propionate/salmeterol Combination 250/50mcg Bid (advair Diskus™) Vs. Salmeterol 50mcg Bid (serevent Diskus™) On Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Rate, Following Acute Exacerbation Or Hospitalization
Ohar, J. A.
Crater, G.
Emmett, A.
Ferro, T.
Morris, A.
Raphiou, I.
Sriram, P.
Dransfield, M. T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[6] Clinical markers of worsening asthma with the fluticasone propionate/salmeterol 100/50 Diskus® (FSC) vs fluticasone propionate (FP) 250mcg alone in patients requiring FP 250 mcg BID for asthma stability
Dorinsky, PM
Yancey, SW
Waiticus-Edwards, K
Edwards, L
CHEST, 2003, 124 (04) : 88S - 88S
[7] Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/100 mcg twice daily and budesonide 400 mcg twice daily in the treatment of adults with asthma in China
Yang, L
Mulligan, AT
VALUE IN HEALTH, 2003, 6 (06) : 777 - 777
[8] Cost-Effectiveness of Fluticasone Propionate/Salmeterol (250/50mcg) Compared to Salmeterol (50mcg) in Patients with Chronic Obstructive Pulmonary Disease: Economic Evaluation of Study SCO100250
Dalal, A. A.
Blanchette, C. M.
Petersen, H.
St Charles, M.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
[9] The salmeterol/fluticasone propionate combination (50/100mcg) via diskus® has a rapid onset of effect in asthma patients on salmeterol or inhaled corticosteroids
Nathan, R
LaForce, C
Mitchell, D
Pearlman, D
Baitinger, L
Woodring, A
House, K
Prillaman, B
Shah, T
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A637 - A637
[10] Impact on quality of life of parents of asthmatic children who received fluticasone propionate 50 mcg or 100 mcg twice daily for asthma.
Mahajan, P
Okamoto, L
Baker, K
Blake, K
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 304 - 304

← 1 2 3 →